4Ziegler E, Mason H J,Baxter P J. Occupational exposure to cytotoxic drugs in two UK oncology wards[J].Occupational and Environmental Medicine, 2002, 59(9) :608.
5Fuchs J, Hengstler J G, Jung D, et al. DNA damage in nurses handling anti-neuoplasctic agents [J]. Mutat Res,1995,342(1-2) :17.
6Sorsa M, Anderson D. Monitoring of occupational exposure to cytostatic anticancer agents[J]. Mutat Res,1996,335(1-2) :253.
7Jakab MG, Major J, Tompa A. Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs[J]. Toxical Environ Health A,2001,62(5) :307.
8Newman A, Valanis G, Schoeny S. Urinary biological monitoring markers of anticancer drug exposure in oncology nurses[J]. Am J Public Health, 1994,84 (5):852.
10Angela SE, Yvonne S.Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs [J] . Occupational and Environmental Medicine, 1994, 51: 229-233.
